Klippel Trenaunay syndrome and the anaesthesiologist
Sir,
We read with interest the article ' Anaesthetic management of a neonate with Kasabach-Merritt syndrome.' [1] We would like to highlight a syndrome with known association to Kasabach-Merritt syndrome (KMS), namely Klippel Trenaunay Weber syndrome. Many anaesthetic concerns are common to both syndromes [ Figure 1 ].
A 13-year-old boy with Klippel Trenaunay syndrome (KTS) was scheduled for left hip disarticulation in our hospital. Due to lymphohaemangiomatous malformation extending to the pelvis, his left lower limb had assumed gigantic proportions rendering him bedbound. Airway and systemic examinations were normal. Cardiology examination with echocardiogram ruled out high output cardiac failure. Blood investigations including coagulation profile were normal. After obtaining high-risk informed consent and ensuring availability of blood and blood products, he was taken up for surgery. His weight was 25 kg and pre-operative haemoglobin was 11.9 g/dl.
After preoxygenation, fentanyl 30 µg, propofol 75 mg, atracurium 12.5 mg was administered and endotracheal intubation performed with 6.5 mm cuffed endotracheal tube. Monitoring was established with standard monitors and intra-arterial line, subclavian central line for blood gas and central venous pressure. Anaesthesia was maintained with oxygen, nitrous oxide and 2% sevoflurane; 3 mg of morphine and 0.5 g of paracetamol infusion. Tranexamic acid 500 mg was administered as intravenous infusion in normal saline.
During the 3 hour surgery, 3000 ml blood loss occurred (145% of the child's blood volume). Intra-operatively, he was transfused 5 units of packed red blood cells (PRBCs), 4 units of fresh frozen plasma, 2 platelet concentrates and was administered 10 ml calcium gluconate. Intra-operative hypotension responded to volume replacement and low-dose dopamine infusion. Intra-operative arterial blood gas and urine output were normal. At the end of surgery, he was electively ventilated in the intensive care unit with morphine infusion for post-operative Letters to Editor epidural haematomas. [4] However, it must be noted that central regional blockade has been carried out safely after ruling out vascular malformations in the central nervous system with computed tomography/magnetic resonance imaging, and ensuring absence of cutaneous lesions overlying the site of needle insertion. [3] Many patients have venous thrombophlebitis (50%) and pulmonary thromboembolism (22%) which may lead to pulmonary hypertension and right ventricular failure. [4] Arteriovenous malformations can produce high output congestive heart failure. Pre-operative cardiology evaluation must be ensured, and deep vein thrombosis prophylaxis must be considered.
If central venous pressure monitoring is planned, ultrasound guidance can help to rule out vascular malformations of the jugular/subclavian veins. [4] Femoral cannulation is better avoided in view of lower limb thrombophlebitis with venous anomalies. As the presence of brain haemangiomas pose a risk for intra-operative haemorrhage, measures must be taken to minimise surges in blood pressure. [4] With the above-mentioned precautions the anaesthesiologist can ensure a favourable outcome in KTS patients undergoing surgery.
analgesia. Post-operative haemoglobin was 8 g/dl, platelets 45,000 mm -3 , prothrombin time 1.16, calcium 6.4 mg/dl, magnesium 1.6 mg/dl. After transfusing 2 units of PRBCs (in view of ongoing blood loss in the surgical drains) and 2 units of platelet concentrates, correcting electrolyte imbalances with supplements of potassium, calcium and magnesium, and tapering dopamine, he was extubated the next day. Rest of the post-operative period was uneventful.
Klippel Trenaunay syndrome is a rare congenital malformation (incidence of 1 out of 27,500 live births) with a triad of venous malformations or varicose veins, cutaneous capillary malformations and bony or soft tissue hypertrophy in affected limbs. [2, 3] The lung, trunk, gastrointestinal tract, neurovascular structures and the bladder may be involved with the presence of vascular malformations. [4] Implications for the anaesthesiologist are many. Firstly, difficult intubation must be anticipated as patients may have facial anomalies, upper airway angiomas and soft tissue hypertrophy in the airway. [3] Secondly, the potential for massive intra-operative haemorrhage must be considered. In KTS, local intravascular coagulation occurs within the malformation, and distal flow has depletion of coagulation factors. [5] KTS is also often associated with disseminated intravascular coagulation and KMS (consumptive coagulopathy and thrombocytopenia). [3] The anaesthesiologist must, therefore, be vigilant with sufficient intravenous access, adequate blood product reserve and appropriate monitoring intra-operatively. Thirdly, central neuraxial blockade is fraught with risk due to haemangiomas and spinal arteriovenous malformations, tendency for coagulation disorders, and venous dilation that can cause A 30-year-old man, weighing 56 kg, with no co-existing illness, was posted for endoscopic excision of left sided nasopharyngeal angiofibroma. His laboratory parameters were normal, pulse rate was 86 beats/min and blood pressure (BP) was 130/80 mmHg during the pre-anaesthetic evaluation. Hypotensive anaesthesia was planned in anticipation of excessive blood loss.
After initiating routine monitoring, and invasive BP via the left radial artery, general anaesthesia was induced with fentanyl and propofol. Neuromuscular blockade was achieved with vecuronium and airway secured with an endotracheal tube. Anaesthesia was maintained with propofol infusion, nitrous oxide in 30% oxygen, and controlled ventilation. Nitroglycerin (glyceryl trinitrate [GTN]) infusion was started at 10 µg/min. There was an increase in pulse rate from 65 to 72 beats/min and minimal change in BP. Anticipating tachycardia, intravenous metoprolol 4 mg was given, which reduced the heart rate to pre-GTN level. Since, the BP did not reach the desired level, we escalated GTN infusion over the next 5 min which had no effect. Analgesia, intravascular volume and patient position were deemed adequate. Suspecting problem with potency of the drug, GTN from two different manufacturers (maintained in cold chain) were tried without any success. GTN was tried even in 5 mg boluses and we ended up using 75 mg of GTN in a span of 15 min. The nasal cavity was packed with adrenaline-soaked gauze before surgery. But adrenaline was not used intra-operatively by the surgeon.
We thought of other conditions like paraganglioma, adrenal pheochromocytoma, and alerted the surgeon. However, the surgeon was confident of the nature of the tumour because of the intra-operative findings. We were contemplating to use sodium nitroprusside. However, the surgeon was satisfied with the surgical field and able to manage without induced hypotension. Total blood loss was 450 ml. Urine sample for metanephrines and vanillylmandelic acid ruled out pheochromocytoma/paraganglioma and histopathology report confirmed angiofibroma.
Anaesthetics agents and many pharmacological agents are used either alone or in combination to achieve the haemodynamic goals during hypotensive anaesthesia. [1] Intravenous GTN is commonly used in the perioperative setting for acute control of hypertension, treat angina, and provide hypotension because of its easy administration, rapid onset of action, easy titrability, rapid termination of action after stopping the infusion, rapid elimination without toxic metabolites, and very few side effects.
Glyceryl trinitrate is very widely used in the acute management of angina. However, the chronic efficacy of nitrates is blunted because of the development of tolerance. Known since the first clinical use of nitrates, [2] the problem of tolerance is a complex phenomenon involving neurohormonal counter-regulation (known as pseudotolerance) as well as intrinsic vascular tolerance. Neurohormonal mechanisms involved in pseudotolerance are not specific to GTN and have been observed with other vasodilators. GTN-induced desensitization of vasodilator responses to nitric oxide (NO) donors and endothelium-derived NO is termed cross-tolerance. An acute loss of GTN efficacy at intermediate to high concentrations in in-vitro experiments is called tachyphylaxis. [2] Multiple theories have been proposed to explain the mechanism of true tolerance; (1) Impaired nitrate bioconversion resulting in diminished NO release [3] and (2) increased NO clearance mediated by the generation of superoxide (O 2 − ). [4] Our suspicion of an inactive/less potent GTN was ruled out by trying the drug manufactured by three different manufacturers. Our concerns were of a
